中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2013年
16期
62-62,63
,共2页
安体舒通片%充血性心力衰竭%疗效
安體舒通片%充血性心力衰竭%療效
안체서통편%충혈성심력쇠갈%료효
Spironolactone tablets%Congestive heart failure%Efficacy
目的对安体舒通治疗慢性充血性心力衰竭(CHF)在临床中的疗效进行观察。方法对我院2010年2月至2012年10月收治的慢性充血性心力衰竭患者121例,随机分为对照组和观察组组。对照组60例,观察组61例。对照组采用常规心力衰竭治疗法,观察组则在常规治疗慢性充血性心力衰竭的基础上,每天一次加服20mg的安体舒通片,两组均进行4周的治疗。两组通过治疗前后,对利用动态心电图监测到的心律失常情况和左心功能进行对比。结果观察组与对照组比较,观察组的各项指标明显优于对照组,心功能得到有效改善(P<0.05);室性心律失常发生率减少(P<0.01)。结论安体舒通片对改善慢性充血性心力衰竭患者的心功能疗效良好,降低了室性心律失常的发生率,有推广意义。
目的對安體舒通治療慢性充血性心力衰竭(CHF)在臨床中的療效進行觀察。方法對我院2010年2月至2012年10月收治的慢性充血性心力衰竭患者121例,隨機分為對照組和觀察組組。對照組60例,觀察組61例。對照組採用常規心力衰竭治療法,觀察組則在常規治療慢性充血性心力衰竭的基礎上,每天一次加服20mg的安體舒通片,兩組均進行4週的治療。兩組通過治療前後,對利用動態心電圖鑑測到的心律失常情況和左心功能進行對比。結果觀察組與對照組比較,觀察組的各項指標明顯優于對照組,心功能得到有效改善(P<0.05);室性心律失常髮生率減少(P<0.01)。結論安體舒通片對改善慢性充血性心力衰竭患者的心功能療效良好,降低瞭室性心律失常的髮生率,有推廣意義。
목적대안체서통치료만성충혈성심력쇠갈(CHF)재림상중적료효진행관찰。방법대아원2010년2월지2012년10월수치적만성충혈성심력쇠갈환자121례,수궤분위대조조화관찰조조。대조조60례,관찰조61례。대조조채용상규심력쇠갈치요법,관찰조칙재상규치료만성충혈성심력쇠갈적기출상,매천일차가복20mg적안체서통편,량조균진행4주적치료。량조통과치료전후,대이용동태심전도감측도적심률실상정황화좌심공능진행대비。결과관찰조여대조조비교,관찰조적각항지표명현우우대조조,심공능득도유효개선(P<0.05);실성심률실상발생솔감소(P<0.01)。결론안체서통편대개선만성충혈성심력쇠갈환자적심공능료효량호,강저료실성심률실상적발생솔,유추엄의의。
Objective Spironolactone on the treatment of chronic congestive heart failure (CHF) in the clinical curative effect observation. Methods The clinical data from February 2010 to October 2012 patients of chronic congestive heart failure patients 121 cases were randomly divided into control group and observation way. Sixty cases of control group and observation group 61 examples. Control group with normal heart failure therapy, the observation group is in the conventional treatment of chronic congestive heart failure, on the basis of once a day and clothing and mg of spironolactone piece, two groups are on the four weeks of treatment. The two groups before and after treatment, the use of dynamic electrocardiogram (DCG) to arrhythmia and left cardiac function were compared. Results The observation group compared with controls, the indicators of the observation group was better than control group, and effectively improve cardiac function (P<0.01); To reduce the incidence of ventricular arrhythmia (P<0.01). Conclusion Spironolactone tablet to improve chronic congestive heart failure patients with cardiac function good curative effect and reduce the incidence of ventricular arrhythmia, promoting significance.